Science News
from research organizations

Researchers predict risk of valvular heart disease

Date:
November 13, 2013
Source:
University of Copenhagen
Summary:
Researchers have identified a clear link between narrowed heart valves and a special lipoprotein in the blood. In the long term, the research may well help to prevent valvular heart disease.
Share:
       
FULL STORY

Researchers at the University of Copenhagen, Rigshospitalet and Herlev Hospital have identified a clear link between narrowed heart valves and a special lipoprotein in the blood. In the long term, the research may well help to prevent valvular heart disease. The new findings have just been published in the Journal of the American College of Cardiology.

Aortic valve stenosis (AS) -- in which the opening of the aortic valve is narrowed -- affects 2-7 percent of the Danish population aged over 65 years. The disease can be fatal, and the only effective treatment at the moment is valve surgery. The condition can be inherited.

"Based on extensive population surveys, we have shown that high levels of lipoprotein(a) in the blood constitute a significant risk factor for developing aortic stenosis in the general Danish population. Thus, the 10 percent of the population with the highest levels of lipoprotein(a) in their blood are two to three times more likely to develop the disease simply on these grounds," says Clinical Professor at the Faculty of Health and Medical Sciences and consultant at Rigshospitalet, Anne Tybjærg-Hansen.

Aortic valve stenosis affects approx. 2-7 percent of the Danish population aged 65 years and over.

The researchers have also shown that the risk of developing aortic stenosis is greatest among people born with a special variant of the so-called LPA gene, a gene variation which means increased levels of lipoprotein(a) throughout a person's entire life. Genetic studies in Denmark support previous international research in the area which shows that the LPA gene plays a key role in the development of aortic stenosis.

Better prevention and fewer surgical interventions

The researchers are hoping that the new research findings can be used to help prevent demanding treatments for aortic stenosis in the population:

"In the short term, we are hoping that our research will inspire the pharmaceutical industry to conduct clinical trials which investigate the effect of reducing lipoprotein(a) levels in the body in relation to aortic stenosis and also coronary heart disease -- including myocardial infarction. Previous studies suggest a causal relationship between myocardial infarction and lipoprotein(a)," says Pia Rørbæk Kamstrup, a consultant at Herlev Hospital, adding:

"Preventative treatments targeted at individuals with very high levels of lipoprotein(a) in their blood can hopefully reduce the number of patients requiring valve surgery and the risks always associated with surgical procedures."


Story Source:

The above story is based on materials provided by University of Copenhagen. Note: Materials may be edited for content and length.


Journal Reference:

  1. Pia R. Kamstrup, Anne Tybjærg-Hansen, Børge G. Nordestgaard. Elevated Lipoprotein(a) and Risk of Aortic Valve Stenosis in the General Population. Journal of the American College of Cardiology, 2013; DOI: 10.1016/j.jacc.2013.09.038

Cite This Page:

University of Copenhagen. "Researchers predict risk of valvular heart disease." ScienceDaily. ScienceDaily, 13 November 2013. <www.sciencedaily.com/releases/2013/11/131113080333.htm>.
University of Copenhagen. (2013, November 13). Researchers predict risk of valvular heart disease. ScienceDaily. Retrieved May 28, 2015 from www.sciencedaily.com/releases/2013/11/131113080333.htm
University of Copenhagen. "Researchers predict risk of valvular heart disease." ScienceDaily. www.sciencedaily.com/releases/2013/11/131113080333.htm (accessed May 28, 2015).

Share This Page: